PrakashR.DarjiMD

PubMed

• A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).
  Vincenti, F., Charpentier, B., Vanrenterghem, Y., Rostaing, L., Bresnahan, B., Darji, P., Massari, P., Mondragon-Ramirez, G. A., Agarwal, M., Di Russo, G., Lin, C. S.,...> ;Am J Transplant. 2010 Mar
• Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant recipients with gastrointestinal tract disorders.
  Darji, P., Vijayaraghavan, R., Thiagarajan, C. M., Sharma, R. K., Subbarao, B., Pishardy, R., Dakshinamurthy, K. V., Vijaykumar, R., Abraham, G., Bhaskar, S., Agarwal,...> ;Transplant Proc. 2008 Sep 01
• High dose DBMC associated tolerance in live-related renal allograft recipients.
  Trivedi, H., Shah, V., Shah, P., Darji, P., Sane, A., Vanikar, A., Trivedi, V., Savani, H., Narayanan, K., Velusami, S., Dalal, S., Shah, S., Shah, T., Pancholi, N., V...> ;Transplant Proc. 2000 Nov